251 related articles for article (PubMed ID: 30646091)
1. Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA2DS2-VASc Score.
Lin YS; Chen YL; Chen TH; Lin MS; Liu CH; Yang TY; Chung CM; Chen MC
JAMA Netw Open; 2018 Aug; 1(4):e180941. PubMed ID: 30646091
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of solitary atrial flutter patients using anticoagulation therapy: a national cohort study.
Chen YL; Lin YS; Wang HT; Liu WH; Chen HC; Chen MC
Europace; 2019 Feb; 21(2):313-321. PubMed ID: 30107472
[TBL] [Abstract][Full Text] [Related]
3. Proposed A
Chen YL; Wang HT; Chen HC; Liu WH; Chong SZ; Hsueh SK; Chung CM; Lin YS
Open Heart; 2021 Jan; 8(1):. PubMed ID: 33514633
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
5. Different Implications of Heart Failure, Ischemic Stroke, and Mortality Between Nonvalvular Atrial Fibrillation and Atrial Flutter-a View From a National Cohort Study.
Lin YS; Chen TH; Chi CC; Lin MS; Tung TH; Liu CH; Chen YL; Chen MC
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733435
[TBL] [Abstract][Full Text] [Related]
6. CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients.
Naccarelli GV; Panaccio MP; Cummins G; Tu N
Am J Cardiol; 2012 May; 109(10):1526-33. PubMed ID: 22360819
[TBL] [Abstract][Full Text] [Related]
7. CHA2DS2-VASC Score Predicts the Risk of Stroke in Patients Hospitalized to the Internal Medicine Department Without Known Atrial Fibrillation.
Lahad K; Maor E; Klempfner R; Grossman C; Druyan A; Ben-Zvi I
J Gen Intern Med; 2022 Oct; 37(13):3355-3360. PubMed ID: 35622270
[TBL] [Abstract][Full Text] [Related]
8. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
9. Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.
Chao TF; Lip GYH; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
J Am Coll Cardiol; 2018 Jan; 71(2):122-132. PubMed ID: 29325634
[TBL] [Abstract][Full Text] [Related]
10. Stroke prediction with CHA
Hu WS; Lin CL
J Clin Neurosci; 2017 Nov; 45():193-198. PubMed ID: 28684149
[TBL] [Abstract][Full Text] [Related]
11. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of first-ever stroke in younger patients with atrial fibrillation not recommended for antithrombotic therapy by current guidelines: a population-based study in an East Asian cohort of 22 million people.
Chang KC; Wang YC; Ko PY; Wu HP; Chen YW; Muo CH; Sung FC; Li TC; Hsu CY
Mayo Clin Proc; 2014 Nov; 89(11):1487-97. PubMed ID: 25444485
[TBL] [Abstract][Full Text] [Related]
13. Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
Lip GYH; Murphy RR; Sahiar F; Ingall TJ; Dhamane AD; Ferri M; Hlavacek P; Preib MT; Keshishian A; Russ C; Rosenblatt L; Yuce H; Deitelzweig S
JAMA Netw Open; 2022 Aug; 5(8):e2229333. PubMed ID: 36044214
[TBL] [Abstract][Full Text] [Related]
14. Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany.
Wicke FS; Schaller MA; Karymova K; Beyer M; Müller BS
BMC Cardiovasc Disord; 2019 Apr; 19(1):94. PubMed ID: 31014253
[TBL] [Abstract][Full Text] [Related]
15. CHA
Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant).
Gažová A; Leddy JJ; Rexová M; Hlivák P; Hatala R; Kyselovič J
Medicine (Baltimore); 2019 Aug; 98(31):e16560. PubMed ID: 31374021
[TBL] [Abstract][Full Text] [Related]
17. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
[TBL] [Abstract][Full Text] [Related]
18. Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Lip GY; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
Stroke; 2016 Oct; 47(10):2462-9. PubMed ID: 27625386
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA
Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Marín F
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28729407
[TBL] [Abstract][Full Text] [Related]
20. Real-World Comparison of Classes IC and III Antiarrhythmic Drugs as an Initial Rhythm Control Strategy in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
Kipp R; Askari M; Fan J; Field ME; Turakhia MP
JACC Clin Electrophysiol; 2019 Feb; 5(2):231-241. PubMed ID: 30784696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
